Generated August 13, 2026 at 8:30 PM ET
· Covers August 13 trading day
· 10 of 352 ready 8-Ks selected
· AI-assisted overview
The day's filings were dominated by M&A and corporate actions. Accelerant Holdings agreed to be acquired by Thoma Bravo in a $4B all-cash deal, while Digital Asset Acquisition Corp. terminated its merger with Old Glory and postponed its meeting. Vireo Growth closed the PharmaCann Colorado acquisition and secured an $85M credit facility. Several regulatory and compliance updates were also notable: Nutex Health highlighted a Fifth Circuit ruling on insurance payment rules, Nocera regained Nasdaq compliance, and Sagimet received FDA clearance for a Phase 3 trial. On the financial side, Pelthos restated Q1 results and reported a Q2 loss, while Nano Nuclear reported strong cash and progress on its reactor program. Artius II Acquisition announced liquidation, and Atlantic International settled a dispute with Circle8, canceling a $35M note.
DAAQ
Digital Asset Acquisition Corp.
M&A
negative
materiality 0.90
August 13, 2026, 5:02 PM ET
Digital Asset Acquisition Corp. terminates merger with Old Glory; meeting postponed
- Mutual termination of Business Combination Agreement dated Jan 13, 2026, effective Aug 13, 2026.
- Extraordinary general meeting scheduled for Aug 14, 2026 indefinitely postponed due to no business.
- No termination fee payable; each party bears its own expenses per Termination Agreement.
M&A
positive
materiality 1.00
August 13, 2026, 7:57 AM ET
Accelerant to be acquired by Thoma Bravo for $20.25/share (49% premium); Q2 EWP up 23%
- All-cash deal valued at >$4B enterprise value; shareholders get $20.25/share, 49% premium to Aug 12 close.
- Expected close H1 2027; Altamont (82% voting) supports; no financing condition; shares to delist from NYSE.
- Q2: Exchange Written Premium $1.32B (+23% YoY); net income $80M, EPS $0.36; adjusted EPS $0.32 (+146%).
M&A
positive
materiality 0.85
August 13, 2026, 7:00 AM ET
Vireo closes PharmaCann Colorado acquisition (17 stores) and secures $85M BMO credit facility
- Acquired PharmaCann Colorado retail assets for ~$48.7M: 3,004,751 subordinate voting shares plus assumed liabilities; 17 dispensaries added, footprint now 56 in Colorado.
- New $85M asset-based revolving credit facility with Bank of Montreal, expandable to $105M, maturing Aug 7, 2031; SOFR+1.75-2.00% or base+0.75-1.00%.
- Proceeds to refinance existing Chicago Atlantic debt and shareholder notes, fund working capital, capex, and permitted acquisitions.
regulatory
positive
materiality 0.75
August 13, 2026, 4:01 PM ET
Fifth Circuit vacates NSA ghost-rate and bonus-exclusion rules; Nutex Health to benefit from higher QPA
- On Aug 11, 2026, en banc Fifth Circuit in Texas Medical Association v. HHS vacated July 2021 Rule allowing ghost rates and excluding bonus/incentive payments from QPA.
- Court ruled insurers must include bonus and incentive payments and cannot use non-negotiated placeholder rates; vacatur upheld with enforcement discretion for existing QPAs until new rules.
- Ruling cites ghost rates suppressed QPA and led IDR arbitration awards exceeding QPA in 85% of cases.
regulatory
positive
materiality 0.65
August 13, 2026, 5:00 PM ET
Nocera regains Nasdaq compliance; sells Alabama land for $700k
- Sold 231 acres in Montgomery County, AL to Timothy and Catherine Rudder for $700k cash; net proceeds ~$654,604 after ~$42,175 in closing costs.
- Property book value was ~$877,870; expects ~$178k loss on sale in Q3 2026.
- Nasdaq confirmed compliance with Listing Rule 5550(b) based on Q2 10-Q showing stockholders' equity of $5,435,030; matter closed.
SGMT
Sagimet Biosciences Inc.
regulatory
positive
materiality 0.60
August 13, 2026, 7:05 AM ET
FDA clears IND for Sagimet's denifanstat Phase 3 acne trial
- FDA issued 'Study May Proceed' letter for Phase 3 trial of denifanstat in moderate to severe acne.
- Denifanstat is a fatty acid synthase inhibitor; trial cleared on August 13, 2026.
- Sagimet announced the IND clearance, enabling initiation of the Phase 3 study.
PTHS
Pelthos Therapeutics Inc.
earnings
negative
materiality 0.90
August 13, 2026, 7:15 AM ET
Pelthos restates Q1 2026 financials; Q2 net loss $23.4M, Zelsuvmi revenue up 45% QoQ
- Restating Q1 2026 (March 31) financials; prior statements no longer reliable per Item 4.02.
- Q2 2026 net loss $(23.4)M vs $(25.1)M Q1; adjusted EBITDA $(5.7)M vs $(8.0)M.
- Zelsuvmi net revenue $15.4M, up 45% QoQ; 11,925 units dispensed by 4,571 prescribers.
AACB
Artius II Acquisition Inc.
other material
negative
materiality 0.95
August 13, 2026, 8:00 AM ET
Artius II Acquisition to liquidate, redeem public shares after failing to close business combination
- Board decided Aug 13, 2026 to liquidate and dissolve; will cease all operations except winding up.
- Public shares redeemed at cash per-share equal to trust account balance (net of taxes and up to $100k expenses) divided by outstanding shares.
- Rights included in IPO units will expire worthless; no redemption rights or liquidating distributions for rights.
NNE
Nano Nuclear Energy Inc.
earnings
positive
materiality 0.85
August 13, 2026, 4:05 PM ET
NANO Nuclear reports Q3 FY26: NRC accepts KRONOS CPA, STS acquisition, $580M cash
- NRC docketed CPA for KRONOS MMR at University of Illinois; expects environmental assessment Q1 2027, safety evaluation Q3 2027.
- Completed acquisition of Secured Transportation Systems (STS); STS 2025 audited revenue $7.1M, net income $1.3M; $3.9M unaudited revenue H1 2026.
- Cash, cash equivalents, and short-term investments total $580M as of June 30, 2026; raised $26M via ATM during Q3.
ATLN
ATLANTIC INTERNATIONAL CORP.
other material
positive
materiality 0.90
August 13, 2026, 5:23 PM ET
Circle8 settles SPP dispute, cancels $35M convertible note; gets Nasdaq bid price deficiency
- Settlement with SPP extinguishes $35M convertible seller's note due March 2027; resolves NY and DE litigation.
- Atlantic issues ~21.98M new shares to SPP; SPP grants 10-yr call option to repurchase same shares at $0.00001 each for retirement.
- SPP to sell shares over ~18 months to repay $62.67M indebtedness; remaining shares returned if repaid early.